CRISPR-Cas13a Targeting the Enhancer RNA-SMAD7e Inhibits Bladder Cancer Development Both in vitro and in vivo
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CRISPR-Cas13a Targeting the Enhancer RNA-SMAD7e Inhibits Bladder Cancer Development Both in vitro and in vivo
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-11-17
DOI
10.3389/fmolb.2020.607740
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs’ cleavage by CRISPR/Cas13a system
- (2020) Yili Chen et al. ANTIVIRAL RESEARCH
- A CRISPR-Cas13a system for efficient and specific therapeutic targeting of mutant KRAS for pancreatic cancer treatment
- (2018) Xiao Zhao et al. CANCER LETTERS
- RNA targeting with CRISPR–Cas13
- (2017) Omar O. Abudayyeh et al. NATURE
- Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas
- (2017) Elodie Bal et al. NATURE MEDICINE
- Single-cell profiling reveals that eRNA accumulation at enhancer–promoter loops is not required to sustain transcription
- (2016) Samir Rahman et al. NUCLEIC ACIDS RESEARCH
- Enhanced Identification of Transcriptional Enhancers Provides Mechanistic Insights into Diseases
- (2016) Yasuhiro Murakawa et al. TRENDS IN GENETICS
- Improving Systemic Chemotherapy for Bladder Cancer
- (2016) Tracy L. Rose et al. Current Oncology Reports
- Coexpression networks identify brain region–specific enhancer RNAs in the human brain
- (2015) Pu Yao et al. NATURE NEUROSCIENCE
- Enhancer transcripts mark active estrogen receptor binding sites
- (2013) N. Hah et al. GENOME RESEARCH
- Immunomodulatory effects of total intravenous and balanced inhalation anesthesia in patients with bladder cancer undergoing elective radical Cystectomy: preliminary results
- (2013) Maria Sofra et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Biomarkers in urothelial carcinoma of the bladder: The potential cross-talk between transforming growth factor-β1 and estrogen receptor β/androgen receptor pathways
- (2013) Yang Xu et al. MEDICAL HYPOTHESES
- Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation
- (2013) Wenbo Li et al. NATURE
- Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription
- (2013) Michael T. Y. Lam et al. NATURE
- Ultra-Rare Mutation in Long-Range Enhancer Predisposes to Thyroid Carcinoma with High Penetrance
- (2013) Huiling He et al. PLoS One
- Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins
- (2012) Alfredo Castello et al. CELL
- Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer
- (2012) M. Racioppi et al. UROLOGIA INTERNATIONALIS
- Inhibitory Smad7: Emerging Roles in Health and Disease
- (2012) Marco A. Briones-Orta et al. Current Molecular Pharmacology
- Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
- (2011) Dong Wang et al. NATURE
- Editorial Comment to Inverse expression of estrogen receptor-β and nuclear factor-κB in urinary bladder carcinogenesis
- (2010) Shigeo Horie INTERNATIONAL JOURNAL OF UROLOGY
- Widespread transcription at neuronal activity-regulated enhancers
- (2010) Tae-Kyung Kim et al. NATURE
- A Large Fraction of Extragenic RNA Pol II Transcription Sites Overlap Enhancers
- (2010) Francesca De Santa et al. PLOS BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started